Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-004418
Filing Date
2025-04-25
Accepted
2025-04-25 12:36:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27695
2 filename2.txt TEXT-EXTRACT 1174
  Complete submission text file 0000000000-25-004418.txt   40370
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filed for) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-286581
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)